Codex DNA - Delisted Stock
Codex DNA is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Codex DNA was actively traded.
Valuation
Check how we calculate scores
Codex DNA Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Codex DNA market risk premium is the additional return an investor will receive from holding Codex DNA long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Codex DNA. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Codex DNA's alpha and beta are two of the key measurements used to evaluate Codex DNA's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.48 | |||
| Standard Deviation | 4.37 | |||
| Variance | 19.13 | |||
| Risk Adjusted Performance | (0.04) |
Codex DNA Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Codex DNA stock to make a market-neutral strategy. Peer analysis of Codex DNA could also be used in its relative valuation, which is a method of valuing Codex DNA by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Codex DNA Corporate Management
Elected by the shareholders, the Codex DNA's board of directors comprises two types of representatives: Codex DNA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Codex. The board's role is to monitor Codex DNA's management team and ensure that shareholders' interests are well served. Codex DNA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Codex DNA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Richard Lepke | Director Relations | Profile | |
| Laura MBA | VP Culture | Profile | |
| Decky MBA | VP Operations | Profile | |
| Laurence Warden | VP Instrumentation | Profile | |
| Brent Hunter | Ex Officer | Profile | |
| Dr MBA | CEO Pres | Profile | |
| Daniel Gibson | Chief Officer | Profile |
Still Interested in Codex DNA?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Codex DNA information on this page should be used as a complementary analysis to other Codex DNA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Codex Stock
If you are still planning to invest in Codex DNA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Codex DNA's history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |